215 related articles for article (PubMed ID: 29356314)
1. Plasma metabolome analysis of patients with major depressive disorder.
Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
3. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
4. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
6. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
7. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
8. Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets.
Ogawa S; Koga N; Hattori K; Matsuo J; Ota M; Hori H; Sasayama D; Teraishi T; Ishida I; Yoshida F; Yoshida S; Noda T; Higuchi T; Kunugi H
J Psychiatr Res; 2018 Jan; 96():23-32. PubMed ID: 28950111
[TBL] [Abstract][Full Text] [Related]
9. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
10. Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.
Kageyama Y; Kasahara T; Nakamura T; Hattori K; Deguchi Y; Tani M; Kuroda K; Yoshida S; Goto YI; Inoue K; Kato T
Int J Neuropsychopharmacol; 2018 Mar; 21(3):207-215. PubMed ID: 29040586
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.
Liu Y; Yieh L; Yang T; Drinkenburg W; Peeters P; Steckler T; Narayan VA; Wittenberg G; Ye J
BMC Genomics; 2016 Aug; 17(1):669. PubMed ID: 27549765
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.
Kageyama Y; Kasahara T; Kato M; Sakai S; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Goto Y; Kinoshita T; Inoue K; Kato T
J Affect Disord; 2018 Jun; 233():15-20. PubMed ID: 28633757
[TBL] [Abstract][Full Text] [Related]
15. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.
Kim EY; Lee MY; Kim SH; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():65-71. PubMed ID: 28223106
[TBL] [Abstract][Full Text] [Related]
17. MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder.
Bilello JA; Thurmond LM; Smith KM; Pi B; Rubin R; Wright SM; Taub F; Henry ME; Shelton RC; Papakostas GI
J Clin Psychiatry; 2015 Feb; 76(2):e199-206. PubMed ID: 25742207
[TBL] [Abstract][Full Text] [Related]
18. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
19. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
20. Comparing the phenomenology of depressive episodes in bipolar I and II disorder and major depressive disorder within bipolar disorder pedigrees.
Frankland A; Cerrillo E; Hadzi-Pavlovic D; Roberts G; Wright A; Loo CK; Breakspear M; Mitchell PB
J Clin Psychiatry; 2015 Jan; 76(1):32-8; quiz 39. PubMed ID: 25650671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
